The clinical efficacy signals further confirm topical pravibismane's potential for achieving ... as novel therapies are greatly needed to address the significant unmet medical needs of patients with ...
These findings from a post hoc analysis were published in Advances in Wound Care. In a phase 3 clinical trial (ClinicalTrials.gov Identifier: NCT01898923), ON101 was associated with better efficacy ...
Additionally, the weakened capacity of angiogenesis in the elderly results in a diminished NPY-mediated angiogenic ability, further restricting its efficacy in wound healing (Reichmann and Holzer, ...